Literature DB >> 34779371

Beneficial Extracardiac Effects of Cardiovascular Medications.

Asra K Butt1, Jay Patel2, Hamid Shirwany3, Qasim Mirza4, Jonathan Hoover5, Rami N Khouzam6.   

Abstract

Cardiovascular diseases are the most common cause of death worldwide, with cardiovascular medications being amongst the most common medications prescribed. These medications have diverse effects on the heart, vascular system, as well as other tissues and organ systems. The extra cardiovascular effects have been found to be of use in the treatment of non-cardiovascular diseases and pathologies. Minoxidil is used to manage systemic hypertension with its well-known side effect of hirsutism used to treat alopecia and baldness. Sildenafil was originally investigated as a treatment option for systemic hypertension; however, its side effect of penile erection led to it being widely used for erectile dysfunction. Alpha-1 blockers such as terazosin are indicated to treat systemic hypertension but are more commonly used for benign prostatic hyperplasia and post-traumatic stress disorder. Beta blockers are the mainstay treatment for congestive heart failure and systemic hypertension but have been found useful to help in patients with intention tremors as well as prophylaxis of migraines. Similarly, calcium channel blockers are indicated in medical expulsion therapy for ureteric calculi in addition to their cardiovascular indications. Thiazides are commonly used for treating systemic hypertension and as diuretics. Thiazides can cause hypocalciuria and hypercalcemia. This side effect has led to thiazides being used to treat idiopathic hypercalciuria and associated nephrolithiasis. Spironolactone is commonly utilized in treating heart failure and as a diuretic for edema. It's well described anti-androgen side effects have been used for acne vulgaris and hirsutism in polycystic ovarian syndrome. This review article discusses how the various extracardiovascular effects of commonly used cardiovascular medications are put to use in managing non-cardiovascular conditions. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Pharmacotherapy; beneficial effects; cardiovascular disease; extracardiovascular; medications; side effects

Mesh:

Substances:

Year:  2022        PMID: 34779371      PMCID: PMC9413730          DOI: 10.2174/1573403X17666211015145132

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


  226 in total

Review 1.  Pharmacology for post-traumatic stress disorder related to childhood sexual abuse: a literature review.

Authors:  Maryhelen C Kreidler; Leslie A Briscoe; Rhonda R Beech
Journal:  Perspect Psychiatr Care       Date:  2002 Oct-Dec       Impact factor: 2.186

Review 2.  Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: A meta-analysis of randomized controlled trials.

Authors:  Dilan E Yücel; Arnold A P van Emmerik; Camille Souama; Jaap Lancee
Journal:  Sleep Med Rev       Date:  2019-11-28       Impact factor: 11.609

3.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman
Journal:  Circulation       Date:  2014-09-23       Impact factor: 29.690

4.  Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin.

Authors:  Y Takeda; I Miyamori; T Yoneda; H Hatakeyama; S Inaba; K Furukawa; H Mabuchi; R Takeda
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

5.  Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.

Authors:  Fiona C Denison; Kathryn F Carruthers; Jemma Hudson; Gladys McPherson; Graham Scotland; Sheonagh Brook-Smith; Cynthia Clarkson; Mathilde Peace; Jane Brewin; Gin Nie Chua; Nina Hallowell; Jane E Norman; Julia Lawton; John Norrie
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

Review 6.  Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data.

Authors:  Francesco Montorsi; Andrew McCullough
Journal:  J Sex Med       Date:  2005-09       Impact factor: 3.802

Review 7.  Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.

Authors:  David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C Price; Xavier Jaïs; Marc Humbert; Gérald Simonneau; Olivier Sitbon
Journal:  Adv Ther       Date:  2009-09-19       Impact factor: 3.845

8.  Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.

Authors:  V C Fiedler-Weiss
Journal:  J Am Acad Dermatol       Date:  1987-03       Impact factor: 11.527

9.  Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010.

Authors:  Cheryl D Fryar; Te-Ching Chen; Xianfen Li
Journal:  NCHS Data Brief       Date:  2012-08

Review 10.  Pharmacological interventions for preventing complications in idiopathic hypercalciuria.

Authors:  Joaquin Escribano; Albert Balaguer; Filomena Pagone; Albert Feliu; Marta Roqué I Figuls
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.